NM_000251.1(MSH2):c.-160G>A AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- Mar 23, 2019
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV002394821.9
Allele description [Variation Report for NM_000251.1(MSH2):c.-160G>A]
NM_000251.1(MSH2):c.-160G>A
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
Homo sapiens growth differentiation factor 9 (GDF9), transcript variant 5, mRNA
Homo sapiens growth differentiation factor 9 (GDF9), transcript variant 5, mRNAgi|1890333374|ref|NM_001288827.3|Nucleotide
-
Nucleotide Links for Protein (Select 1034580738) (2)
Nucleotide
-
GSE3034[ACCN] AND gsm[ETYP] (13)
GEO DataSets
-
Homo sapiens ORMDL sphingolipid biosynthesis regulator 1 (ORMDL1), transcript va...
Homo sapiens ORMDL sphingolipid biosynthesis regulator 1 (ORMDL1), transcript variant 3, mRNAgi|1700611607|ref|NM_001371384.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 10, 2024